![](/img/cover-not-exists.png)
TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-β treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response
Mathias Buttmann, Cornelia Merzyn, Harald H. Hofstetter, Peter RieckmannVolume:
190
Year:
2007
Language:
english
Pages:
7
DOI:
10.1016/j.jneuroim.2007.08.009
File:
PDF, 278 KB
english, 2007